United States & Kenvue
6 shared events · Importance 3 · Last updated Jul 31, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States: Jurisdiction; political involvement via Trump administration; FDA and CDC mentioned.
Kenvue: Primary defendant; faces revived lawsuits alleging failure to warn about autism/ADHD risk. Stock fell 1% on ruling.
Jul 13, 2026 · 23 articles
Business
United States: US state EPR laws create a favorable regulatory environment for Greyparrot's expansion.
Kenvue: Kenvue partnered with Greyparrot to improve recycling for its packaging, using Deepnest to validate performance.
Jul 28, 2026 · 6 articles
Business
United States: The United States is a major market where Kimberly-Clark saw a slight volume decline due to inflation and consumer spending cuts. This adds to the company's challenges.
Kenvue: Kenvue is the target of Kimberly-Clark's roughly $40 billion acquisition, expected to close by year-end. The acquisition is part of Kimberly-Clark's strategy, though the China disruption may affect the deal's timing or financing.
Aug 04, 2026 · 6 articles
Business
United States: The settlement resolves claims in U.S. federal and state courts, covering nearly all remaining talc lawsuits in the country.
Kenvue: Kenvue, J&J's former consumer health business, holds liability for Johnson's baby powder outside North America but is not directly involved in the U.S. settlement.
Jul 27, 2026 · 82 articles
Tech
Kenvue: Kenvue, the manufacturer of Tylenol (paracetamol), faced a lawsuit regarding alleged links between its product and autism, which was dismissed. The new study supports the safety of its product.
Jan 16, 2026 · 23 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Kenvue interact across events, view sentiment trends, and discover connected entities.
Open Dashboard